These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24122631)

  • 1. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.
    Oue N; Anami K; Schetter AJ; Moehler M; Okayama H; Khan MA; Bowman ED; Mueller A; Schad A; Shimomura M; Hinoi T; Aoyagi K; Sasaki H; Okajima M; Ohdan H; Galle PR; Yasui W; Harris CC
    Int J Cancer; 2014 Apr; 134(8):1926-34. PubMed ID: 24122631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
    Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
    JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
    Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
    Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
    Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
    Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of a metastasis-specific microRNA signature in primary colon cancer.
    Coebergh van den Braak RRJ; Sieuwerts AM; Lalmahomed ZS; Smid M; Wilting SM; Bril SI; Xiang S; van der Vlugt-Daane M; de Weerd V; van Galen A; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; ; Martens JWM; IJzermans JNM
    Sci Rep; 2018 Mar; 8(1):5242. PubMed ID: 29588449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
    Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
    Donada M; Bonin S; Nardon E; De Pellegrin A; Decorti G; Stanta G
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):201-10. PubMed ID: 20387074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
    Schetter AJ; Nguyen GH; Bowman ED; Mathé EA; Yuen ST; Hawkes JE; Croce CM; Leung SY; Harris CC
    Clin Cancer Res; 2009 Sep; 15(18):5878-87. PubMed ID: 19737943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of MicroRNA-21 Expression in Patients with Unresectable Metastatic Colon Cancer.
    Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Ikeya T; Matsutani S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    Anticancer Res; 2016 Oct; 36(10):5145-5151. PubMed ID: 27798874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
    Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
    Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.
    Hwang JH; Voortman J; Giovannetti E; Steinberg SM; Leon LG; Kim YT; Funel N; Park JK; Kim MA; Kang GH; Kim SW; Del Chiaro M; Peters GJ; Giaccone G
    PLoS One; 2010 May; 5(5):e10630. PubMed ID: 20498843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma.
    Voortman J; Goto A; Mendiboure J; Sohn JJ; Schetter AJ; Saito M; Dunant A; Pham TC; Petrini I; Lee A; Khan MA; Hainaut P; Pignon JP; Brambilla E; Popper HH; Filipits M; Harris CC; Giaccone G
    Cancer Res; 2010 Nov; 70(21):8288-98. PubMed ID: 20978195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V; Topolcan O; Kucera R; Kripnerova M; Srbecka K; Hora M; Hes O; Klecka J; Babuska V; Rousarova M; Benson V; Pesta M
    Anticancer Res; 2016 Sep; 36(9):4787-93. PubMed ID: 27630329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.